Latest filing published 16 Aug 2016 for Protagonist Therapeutics, Inc.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Julie Papanek: trading record in brief
All filings by Julie Papanek on record concern Protagonist Therapeutics, Inc. Altogether 2 filings, all relating to 16 August 2016.
On the market, this insider has only ever bought: 1 purchase, €6.2M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 16 August 2016: a transaction, in Protagonist Therapeutics, Inc. The last insider purchase was made public on 16 August 2016, 3,737 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Julie Papanek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,869,922 sharesCommon StockSEC:0001209191-16-137322:0
- 583,333 shares@ US$12.00100.0% of flowCommon StockSEC:0001209191-16-137322:1Canonical exit: 14 Nov 2016 (T+90)
2 of 1 declaration
